{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:53:20Z","timestamp":1769079200474,"version":"3.49.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaip.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T05:08:54Z","timestamp":1630991334000},"page":"3258-3266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders"],"prefix":"10.1016","volume":"9","author":[{"given":"Robbie D.","family":"Pesek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Lopez-Nunez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Bernieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Straumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.06.002_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jaip.2021.06.002_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.anai.2018.06.013","article-title":"Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis","volume":"121","author":"Egan","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13441","article-title":"Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"43","author":"Arias","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2021.06.002_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000000228","article-title":"Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium","volume":"114","author":"Pesek","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MPG.0000000000000865","article-title":"Prevalence of eosinophilic gastritis, gastroenteritis, and colits: estimates from a national administrative database","volume":"62","author":"Jensen","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.06.002_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.gtc.2014.02.007","article-title":"Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases","volume":"43","author":"Collins","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaip.2021.06.002_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2021.06.002_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/modpathol.2010.221","article-title":"Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content","volume":"24","author":"Lwin","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2021.06.002_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ajg.2014.166","article-title":"Eosinophilic gastritis in children: clinicopathologic correlation, disease course, and response to therapy","volume":"109","author":"Ko","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)36963-X","article-title":"Prospective evaluation of a novel, endoscopic activity assessment system for eosinophilic gastritis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.mpg.0000221903.61157.4e","article-title":"Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up","volume":"42","author":"Chehade","year":"2006","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.06.002_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00383-020-04832-8","article-title":"Eosinophilic colitis in children: a new and elusive enemy","volume":"37","author":"Raffaele","year":"2021","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jaip.2021.06.002_bib14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1572-0241.2007.01379.x","article-title":"Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children","volume":"102","author":"Aceves","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MPG.0b013e31817f0197","article-title":"Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis","volume":"48","author":"Pentiuk","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.06.002_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cgh.2014.05.021","article-title":"Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis","volume":"13","author":"Gupta","year":"2015","journal-title":"Clin Gastro Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cgh.2012.03.018","article-title":"Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib20","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-Interleukin-5 antibody treatment (mepolizumab) in active eosinophilic esophagitis: a randomized, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2021.06.002_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ajg.2009.657","article-title":"Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.14309\/ajg.0000000000000957","article-title":"Dilation modifies association between symptoms and esophageal eosinophilia in adult patients with eosinophilic esophagitis","volume":"115","author":"Safroneeva","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/all.12879","article-title":"A\u00a0new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families","volume":"71","author":"Straumann","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.06.002_bib27","first-page":"1","article-title":"Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts","volume":"32","author":"Peterson","year":"2019","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2021.06.002_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10620-020-06230-5","article-title":"Image analysis of eosinophil peroxidase immunohistochemistry for diagnosis of eosinophilic esophagitis","volume":"66","author":"Wright","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2021.06.002_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/all.12096","article-title":"Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis","volume":"68","author":"Straumann","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.06.002_bib30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cgh.2019.08.055","article-title":"Persistent basal cell hyperplasia is associated with clinical and endoscopic findings in patients with histologically inactive eosinophilic esophagitis","volume":"18","author":"Welan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib33","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2021.06.002_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/PAS.0000000000001361","article-title":"Budesonide oral suspension significantly improves eosinophilic esophagitis histology scoring system results: analyses from a 12-week, phase 2, randomized, placebo-controlled trial","volume":"43","author":"Collins","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2021.06.002_bib35","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cgh.2014.02.039","article-title":"Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis","volume":"12","author":"Katzka","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib38","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MPG.0000000000002637","article-title":"Eosinophilic esophagitis histology remission score: significant relations to measures of disease activity and symptoms","volume":"70","author":"Collins","year":"2020","journal-title":"J\u00a0Pediatr Gastro Nutr"},{"key":"10.1016\/j.jaip.2021.06.002_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2018.05.014","article-title":"Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites","volume":"142","author":"Aceves","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib40","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-b1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jaci.2015.03.004","article-title":"Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease","volume":"135","author":"Martin","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib42","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jaci.2013.02.042","article-title":"Anti-IL-5 therapy reduces mast cells and IL-9 cells in pediatric eosinophilic esophagitis","volume":"131","author":"Otani","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2010.12.1118","article-title":"Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy","volume":"127","author":"Hsu Blatman","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2014.07.034","article-title":"Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients","volume":"13","author":"Wolf","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib45","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec 8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jaip.2021.06.002_bib46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/gast.2002.32998","article-title":"Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate","volume":"122","author":"Teitelbaum","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.pas.0000213392.49698.8c","article-title":"Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus","volume":"31","author":"Lucendo","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2021.06.002_bib48","first-page":"99","article-title":"Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease","volume":"39","author":"Tantibhaedhyangkul","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jaip.2021.06.002_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.aller.2019.02.005","article-title":"Increased number of regulatory T cells in esophageal tissue of patients with eosinophilic esophagitis in comparison to gastro esophageal reflux disease and control groups","volume":"47","author":"Mousavinasab","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2021.06.002_bib50","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2021.06.002_bib51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.32074\/1591-951X-156","article-title":"Non gastro-esophageal reflux disease related esophagitis: an overview with a histologic diagnostic approach","volume":"112","author":"Mastracci","year":"2020","journal-title":"Pathologica"},{"key":"10.1016\/j.jaip.2021.06.002_bib52","doi-asserted-by":"crossref","first-page":"9303858","DOI":"10.1155\/2016\/9303858","article-title":"Prevalence of eosinophilic esophagitis and lymphocytic esophagitis in adults with esophageal food bolus impaction","volume":"2016","author":"Truskaite","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jaip.2021.06.002_bib53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jclinpath-2016-203782","article-title":"Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: histological and immunohistochemical findings","volume":"70","author":"Rubio","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaip.2021.06.002_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.iac.2008.09.004","article-title":"The role of the high affinity IgE receptor, FcepsilonR1, in eosinophilic gastrointestinal diseases","volume":"29","author":"Dehlink","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.jaip.2021.06.002_bib55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaci.2013.07.046","article-title":"Basophils and allergic inflammation","volume":"132","author":"Siracusa","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/apt.13141","article-title":"Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia","volume":"41","author":"Iwakura","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2021.06.002_bib57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2007.06.015","article-title":"Anti-IgE treatment of eosinophil associated gastrointestinal disorders","volume":"120","author":"Foroughi","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib58","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histological eosinophilic gastritis is a systemic disorder associated with blood and extra-gastric eosinophilia, Th2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib61","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1055\/s-0034-1377781","article-title":"Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability","volume":"46","author":"van Rhijn","year":"2014","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaip.2021.06.002_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cgh.2015.08.040","article-title":"Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment","volume":"14","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib63","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/nmo.12872","article-title":"The endoscopic reference score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis","volume":"28","author":"van Rhijn","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaip.2021.06.002_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/apt.13845","article-title":"The endoscopic reference score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitis","volume":"45","author":"Rodr\u00edguez-S\u00e1nchez","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2021.06.002_bib66","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cgh.2017.12.019","article-title":"Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children","volume":"16","author":"Wechsler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib67","doi-asserted-by":"crossref","first-page":"E165","DOI":"10.1055\/s-0043-122882","article-title":"Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response","volume":"6","author":"Ishimura","year":"2018","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.jaip.2021.06.002_bib68","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/j.gastro.2014.08.028","article-title":"Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis","volume":"147","author":"Schoepfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib69","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib70","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib71","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cgh.2011.01.017","article-title":"Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis","volume":"9","author":"Straumann","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.002_bib72","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1053\/j.gastro.2008.02.016","article-title":"Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups","volume":"134","author":"Kapel","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.002_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/1744666X.2019.1544893","article-title":"Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications","volume":"15","author":"Ruffner","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gene.2014.27","article-title":"Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing","volume":"15","author":"Sherrill","year":"2014","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaip.2021.06.002_bib75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.2000973","article-title":"Conserved IFN signature between adult and pediatric eosinophilic esophagitis","volume":"206","author":"Ruffner","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib76","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2005.01.017","article-title":"Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases","volume":"115","author":"Simon","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib77","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/mai.2002.121458","article-title":"The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis","volume":"109","author":"Spergel","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib78","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jaci.2020.04.024","article-title":"Environmental factors in epithelial barrier dysfunction","volume":"145","author":"S\u00f6zener","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MPG.0b013e3181788282","article-title":"14 years of eosinophilic esophagitis: clinical features and prognosis","volume":"48","author":"Spergel","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.06.002_bib80","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bpg.2015.09.005","article-title":"Clinical features of eosinophilic esophagitis in children and adults","volume":"29","author":"Miehlke","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaip.2021.06.002_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.anai.2019.12.011","article-title":"Phenotypes and endotypes in eosinophilic esophagitis","volume":"124","author":"Ruffner","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations in children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.002_bib83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gtc.2014.02.009","article-title":"Clinical presentation of eosinophilic esophagitis in adults","volume":"43","author":"Falk","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaip.2021.06.002_bib84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2014.02.015","article-title":"Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis","volume":"43","author":"Hirano","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaip.2021.06.002_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/doy015","article-title":"Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course","volume":"31","author":"Shaheen","year":"2018","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2021.06.002_bib86","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.gie.2017.12.020","article-title":"Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis","volume":"87","author":"Wang","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2021.06.002_bib87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.gie.2019.11.031","article-title":"Correlation of endoscopic signs and mucosal alterations in children with eosinophilic esophagitis","volume":"91","author":"Hiremath","year":"2020","journal-title":"Gastrointest Endosc"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982100653X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982100653X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:12Z","timestamp":1761975012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982100653X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S221321982100653X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}